.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fish and Richardson
QuintilesIMS
Merck
Daiichi Sankyo
Chinese Patent Office
Baxter
Covington
Boehringer Ingelheim
Express Scripts
Medtronic

Generated: June 23, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 090711

« Back to Dashboard
NDA 090711 describes NICOTINE POLACRILEX, which is a drug marketed by Actavis Labs Ny Inc, Perrigo R And D, Watson Labs, Ivax Sub Teva Pharms, and L Perrigo Co, and is included in thirty-four NDAs. It is available from forty-two suppliers. Additional details are available on the NICOTINE POLACRILEX profile page.

The generic ingredient in NICOTINE POLACRILEX is nicotine polacrilex. There are twenty-nine drug master file entries for this compound. Forty-five suppliers are listed for this compound. Additional details are available on the nicotine polacrilex profile page.

Summary for NDA: 090711

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 090711

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NICOTINE POLACRILEX
nicotine polacrilex
TROCHE/LOZENGE;ORAL 090711 ANDA Walgreen Company 0363-0124 0363-0124-05 3 CONTAINER in 1 CARTON (0363-0124-05) > 24 LOZENGE in 1 CONTAINER
NICOTINE POLACRILEX
nicotine polacrilex
TROCHE/LOZENGE;ORAL 090711 ANDA Walgreen Company 0363-0124 0363-0124-06 4 CONTAINER in 1 CARTON (0363-0124-06) > 24 LOZENGE in 1 CONTAINER

Summary for product number 001

Active Rx/OTC/Discontinued:OTCDosage:TROCHE/LOZENGE;ORALStrengthEQ 2MG BASE
Approval Date:Jul 10, 2009TE:RLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:OTCDosage:TROCHE/LOZENGE;ORALStrengthEQ 4MG BASE
Approval Date:Jul 10, 2009TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
US Army
Fish and Richardson
Covington
Cantor Fitzgerald
Cerilliant
Harvard Business School
Dow
Novartis
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot